Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04452526 · ClinicalTrials.gov registry record · NA
I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination
A NA study of Cervical Carcinoma and Human Papillomavirus-Related Malignant Neoplasm, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 372
- Enrollment target
- 4
- Study locations
NCT04452526: Active NA study of Cervical Carcinoma and Human Papillomavirus-Related Malignant Neoplasm, sponsored by Ohio State University Comprehensive Cancer Center.
NCT04452526 is a NA study of Cervical Carcinoma and Human Papillomavirus-Related Malignant Neoplasm that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 372 participants, below the 521-participant average among 25 other Cervical Carcinoma trials with a reported enrollment target (29% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04452526, a NA study of Cervical Carcinoma and Human Papillomavirus-Related Malignant Neoplasm, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 372 participants
- Enrollment target
- 4
- Study locations
Study Summary
This trial studies how well a multi-level health system-based intervention works in improving human papillomavirus (HPV) vaccine initiation and completion among children in health systems in four Appalachian states. Utilizing educational and promotional materials and electronic health record reminders, may improve the uptake of the HPV vaccine in children and young adults, ultimately preventing the development of cervical cancer.
Primary Outcome
The effectiveness of the intervention will be assessed by comparing early vs delayed intervention clinics at the end of the first implementation phase adjusting for baseline rates and pre- versus (vs) post implementation rates in the delayed implementation clinics.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Educational Intervention
- OTHER Reminder
Study Locations (4)
Kentucky
- University of Kentucky/Markey Cancer Center - Lexington
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Virginia
- University of Virginia - Charlottesville
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2020-10-21 |
| Est. Completion | 2025-09 |
| Phase | NA |
What the registry record for NCT04452526 still lists
NCT04452526 is an interventional study that assigns participants to a tested intervention. The registered 372 participants enrollment target is mid-sized for trials with a published cap, below the 521-participant average among 25 other Cervical Carcinoma trials with a reported enrollment target (29% lower).
The record links to 2 conditions, with Cervical Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT04452526 reports a single indexed study location in Kentucky, Ohio, Virginia.
Frequently Asked Questions
What is clinical trial NCT04452526 about?
NCT04452526 is a clinical study titled "I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination". This trial studies how well a multi-level health system-based intervention works in improving human papillomavirus (HPV) vaccine initiation and completion among children in health systems in four Appalachian states. Utilizing educational and promotional materials and electronic health record reminde...
What is the current status of trial NCT04452526?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 372 participants. The study started on 2020-10-21. Estimated completion is 2025-09.
What conditions does trial NCT04452526 study?
This clinical trial studies the following conditions: Cervical Carcinoma, Human Papillomavirus-Related Malignant Neoplasm.
What interventions are being tested in trial NCT04452526?
The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Educational Intervention (OTHER), Reminder (OTHER).
Who is sponsoring clinical trial NCT04452526?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04452526 being conducted?
This trial has 4 study locations across Kentucky, Ohio, Virginia, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04452526's enrollment target sits among peer trials
372 8th of 25 higher than 18 of 25 other Cervical Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
RECRUITING · NA
-
The Ohio State University (OSU) SCREEN Community Program
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
ACTIVE NOT RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- NCT05318105 · 372 participants · NA
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
- NCT06797635 · 372 participants · Phase 2
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI